Processing ./eng_groups2016-xml-v2\ACETYLCHOLINESTERASE-INHIBITORS.xml
Processing ./eng_groups2016-xml-v2\ADRENALINE-(ORAL-DENTAL-OR-SUB-CUTANEOUS).xml
Processing ./eng_groups2016-xml-v2\AGONIST OPIOID ANALGESICS.xml
Processing ./eng_groups2016-xml-v2\AGONIST-ANTAGONIST-OPIOIDS.xml
Processing ./eng_groups2016-xml-v2\ALPHA-AND-BETA-SYMPATHOMIMETICS-(IM-AND-IV-ROUTES).xml
Processing ./eng_groups2016-xml-v2\ALPHA-BLOCKERS-FOR-UROLOGICAL-USE.xml
Processing ./eng_groups2016-xml-v2\ALPHA-SYMPATHOMIMETICS-(ORAL-AND-OR-NASAL).xml
Processing ./eng_groups2016-xml-v2\ALUMINUM-(SALTS).xml
Processing ./eng_groups2016-xml-v2\AMINOGLYCOSIDES.xml
Processing ./eng_groups2016-xml-v2\AMINOPENICILLINS.xml
Processing ./eng_groups2016-xml-v2\ANDROGENS.xml
Processing ./eng_groups2016-xml-v2\ANGIOTENSIN-CONVERTING-ENZYME-INHIBITORS-(ACE-INHIBITORS).xml
Processing ./eng_groups2016-xml-v2\ANGIOTENSIN-II-RECEPTOR-ANTAGONISTS-or-ANGIOTENSIN-RECEPTOR-BLOCKERS-(ARBs).xml
Processing ./eng_groups2016-xml-v2\ANTABUSE-(REACTION).xml
Processing ./eng_groups2016-xml-v2\ANTI-LYMPHOCYTE GLOBULINS.xml
Processing ./eng_groups2016-xml-v2\ANTI-TNF-ALPHA.xml
Processing ./eng_groups2016-xml-v2\ANTIARRHYTHMIC-AGENTS.xml
Processing ./eng_groups2016-xml-v2\ANTIBACTERIAL-SULFONAMIDES.xml
Processing ./eng_groups2016-xml-v2\ANTICONVULSANT-ENZYMATIC-INDUCERS.xml
Processing ./eng_groups2016-xml-v2\ANTIEMITIC-NEUROLEPTICS.xml
Processing ./eng_groups2016-xml-v2\ANTIHYPERTENSIVE-ALPHA-BLOCKERS.xml
Processing ./eng_groups2016-xml-v2\ANTIHYPERTENSIVES-EXCEPT-ALPHA-BLOCKERS.xml
Processing ./eng_groups2016-xml-v2\ANTIPARASITICS-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.xml
Processing ./eng_groups2016-xml-v2\ANTIPARKINSONIAN-ANTICHOLINERGICS.xml
Processing ./eng_groups2016-xml-v2\ANTIPARKINSONIAN-DOPAMINERGICS.xml
Processing ./eng_groups2016-xml-v2\ANTIPSYCHOTIC-NEUROLEPTICS-(EXCEPT-CLOZAPINE).xml
Processing ./eng_groups2016-xml-v2\ANTIPURINES.xml
Processing ./eng_groups2016-xml-v2\ATROPINIC-MEDICATIONS.xml
Processing ./eng_groups2016-xml-v2\ATTENUATED-LIVE-VIRUS-VACCINES.xml
Processing ./eng_groups2016-xml-v2\AZOLE-ANTIFUNGALS.xml
Processing ./eng_groups2016-xml-v2\BARBITURATES.xml
Processing ./eng_groups2016-xml-v2\BENZODIAZEPINES-AND-RELATED.xml
Processing ./eng_groups2016-xml-v2\BETA-2-MIMETICS-or-BETA2-ADRENERGIC-AGONISTS.xml
Processing ./eng_groups2016-xml-v2\BETA-BLOCKING-AGENTS-(EXCEPT-ESMOLOL).xml
Processing ./eng_groups2016-xml-v2\BETA-BLOCKING-AGENTS-(EXCEPT-ESMOLOL-AND-SOTALOL).xml
Processing ./eng_groups2016-xml-v2\BETA-BLOCKING-AGENTS-IN-HEART-FAILURE.xml
Processing ./eng_groups2016-xml-v2\BILE-ACIDS.xml
Processing ./eng_groups2016-xml-v2\BISPHOSPHONATES.xml
Processing ./eng_groups2016-xml-v2\BLOOD-GLUCOSE-LOWERING-SULFONAMIDES.xml
Processing ./eng_groups2016-xml-v2\BRADYCARDIA-INDUCING-DRUGS.xml
Processing ./eng_groups2016-xml-v2\CALCIUM-CHANNEL-BLOCKERS.xml
Processing ./eng_groups2016-xml-v2\CENTRAL-ANTIHYPERTENSIVES.xml
Processing ./eng_groups2016-xml-v2\CHELATING-RESINS.xml
Processing ./eng_groups2016-xml-v2\CITRATES.xml
Processing ./eng_groups2016-xml-v2\CLASS-I-ANTIARYTHMICS-(EXCEPT-LIDOCAINE).xml
Processing ./eng_groups2016-xml-v2\CLASS-IA-ANTIARRYTHMICS.xml
Processing ./eng_groups2016-xml-v2\COMBINED-ESTROGEN-PROGESTIN-CONTRACEPTIVES.xml
Processing ./eng_groups2016-xml-v2\CURARES.xml
Processing ./eng_groups2016-xml-v2\CYTOTOXICS.xml
Processing ./eng_groups2016-xml-v2\DERIVATIVES-OF-AMINOSALICYLIC-ACID-(ASA).xml
Processing ./eng_groups2016-xml-v2\DEXTRAN-40.xml
Processing ./eng_groups2016-xml-v2\DIHYDROPYRIDINES.xml
Processing ./eng_groups2016-xml-v2\DIRECT-THROMBIN-INHIBITORS.xml
Processing ./eng_groups2016-xml-v2\DIURETICS.xml
Processing ./eng_groups2016-xml-v2\DOPAMINERGIC-ALKALOIDS-OF-ERGOT-OF-RYE.xml
Processing ./eng_groups2016-xml-v2\DOPAMINERGICS,-EXCEPT-PARKINSON.xml
Processing ./eng_groups2016-xml-v2\DOPAMINERGICS.xml
Processing ./eng_groups2016-xml-v2\ENZYMATIC-INDUCERS.xml
Processing ./eng_groups2016-xml-v2\FIBRATES.xml
Processing ./eng_groups2016-xml-v2\FLUOROQUINOLONES.xml
Processing ./eng_groups2016-xml-v2\FLUOROURACIL (AND, BY EXTRAPOLATION, OTHER FLUOROPYRIMIDINES).xml
Processing ./eng_groups2016-xml-v2\FOLATES.xml
Processing ./eng_groups2016-xml-v2\GASTRO-INTESTINAL-TARGETED-MEDICATIONS,-ANTACIDS,-AND-ABSORBANTS.xml
Processing ./eng_groups2016-xml-v2\GLINIDES.xml
Processing ./eng_groups2016-xml-v2\GLIPTINS.xml
Processing ./eng_groups2016-xml-v2\GLUCOCORTICOIDS-(EXCEPT-HYDROCORTISONE).xml
Processing ./eng_groups2016-xml-v2\H2-RECEPTOR-ANTAGONISTS.xml
Processing ./eng_groups2016-xml-v2\HALOGENATED-HYDROCARBON-ANESTHETICS.xml
Processing ./eng_groups2016-xml-v2\HEPARINS.xml
Processing ./eng_groups2016-xml-v2\HMG-COA-REDUCTASE-INHIBITORS-(STATINS).xml
Processing ./eng_groups2016-xml-v2\HYPERKALEMIA-INDUCING-MEDICATIONS.xml
Processing ./eng_groups2016-xml-v2\HYPNOTICS.xml
Processing ./eng_groups2016-xml-v2\HYPONATREMIA-INDUCING-MEDICATIONS.xml
Processing ./eng_groups2016-xml-v2\IMMUNOSUPPRESSANTS.xml
Processing ./eng_groups2016-xml-v2\INDIRECT SYMPATHOMIMETICS.xml
Processing ./eng_groups2016-xml-v2\INHIBITORS-OF-CATECHOL-O-METHYLTRANSFERASE-(COMT).xml
Processing ./eng_groups2016-xml-v2\INSULIN.xml
Processing ./eng_groups2016-xml-v2\IODINATED-X-RAY-CONTRAST-MEDIA.xml
Processing ./eng_groups2016-xml-v2\IRREVERSIBLE-MONOAMINE-OXIDASE-INHIBITORS-(MAOI).xml
Processing ./eng_groups2016-xml-v2\LINCOSANIDES.xml
Processing ./eng_groups2016-xml-v2\LOOP-DIURETICS.xml
Processing ./eng_groups2016-xml-v2\LOW-MOLECULAR-WEIGHT-HEPARINS-AND-RELATED-DRUGS-(CURATIVE-DOSES-AND-OR-OLDER-PATIENT).xml
Processing ./eng_groups2016-xml-v2\LOW-MOLECULAR-WEIGHT-HEPARINS-AND-RELATED-DRUGS-(PREVENTIVE-DOSES).xml
Processing ./eng_groups2016-xml-v2\MACROLIDES-(EXCEPT-SPIRAMYCIN).xml
Processing ./eng_groups2016-xml-v2\MEDICATIONS-AT-RISK-WHEN-WITHDRAWING-FROM-TOBACCO.xml
Processing ./eng_groups2016-xml-v2\MEDICATIONS-AT-THE-ORIGIN-OF-A-SEROTONIN-SYNDROME.xml
Processing ./eng_groups2016-xml-v2\MEDICATIONS-AT-THE-ORIGIN-OF-ORTHOSTATIC-HYPOTENSION.xml
Processing ./eng_groups2016-xml-v2\MEDICATIONS-THAT-LOWER-BLOOD-PRESSURE.xml
